Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
75 | NTP Technical Report on the Toxicity Studies Series | book series | 0 | 3 | 0 | 369 | 0 | 0 | 0.00 | 123.00 | ||
74 | World Cancer Research Journal | journal | 2 | 48 | 0 | 1636 | 0 | 0 | 0.00 | 34.08 | ||
73 | Sub-Cellular Biochemistry | journal | 2.165 Q1 | 75 | 49 | 124 | 6127 | 685 | 1 | 4.30 | 125.04 | |
72 | Journal of Experimental Therapeutics and Oncology | journal | 0.107 Q4 | 39 | 0 | 15 | 0 | 2 | 14 | 0.20 | 0.00 | |
71 | NanoWorld Journal | journal | 0.188 Q4 | 4 | 41 | 26 | 1787 | 31 | 23 | 1.53 | 43.59 | |
70 | Genes and Cancer | journal | 0.821 Q3 | 78 | 9 | 33 | 541 | 91 | 32 | 1.95 | 60.11 | |
69 | Current Pathobiology Reports | journal | 0.560 Q3 | 29 | 3 | 38 | 342 | 115 | 38 | 3.00 | 114.00 | |
68 | Journal of the National Cancer Institute. Monographs | journal | 1.541 Q1 | 91 | 23 | 58 | 762 | 281 | 54 | 4.43 | 33.13 | |
67 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 0.533 Q3 | 57 | 15 | 56 | 984 | 177 | 55 | 2.59 | 65.60 | |
66 | Drug Resistance Updates | journal | 4.391 Q1 | 125 | 28 | 65 | 5855 | 1576 | 65 | 23.73 | 209.11 | |
65 | Annual Review of Cancer Biology | book series | 4.599 Q1 | 32 | 17 | 67 | 2215 | 686 | 67 | 7.70 | 130.29 | |
64 | Journal of Immunotherapy and Precision Oncology | journal | 0.393 Q4 | 7 | 15 | 89 | 449 | 72 | 67 | 0.77 | 29.93 | |
63 | Annals of Cancer Research and Therapy | journal | 0.135 Q4 | 7 | 23 | 82 | 638 | 21 | 81 | 0.28 | 27.74 | |
62 | Critical Reviews in Oncogenesis | journal | 0.395 Q4 | 54 | 16 | 98 | 1254 | 133 | 81 | 0.98 | 78.38 | |
61 | Journal of Mammary Gland Biology and Neoplasia | journal | 0.705 Q3 | 108 | 16 | 91 | 1231 | 200 | 86 | 2.13 | 76.94 | |
60 | Tumor Biology | journal | 0.645 Q3 | 97 | 19 | 97 | 601 | 270 | 96 | 2.63 | 31.63 | |
59 | Journal of Immunotherapy | journal | 1.397 Q2 | 103 | 52 | 145 | 1958 | 642 | 144 | 3.78 | 37.65 | |
58 | Current Hematologic Malignancy Reports | journal | 0.914 Q2 | 40 | 31 | 162 | 2200 | 556 | 162 | 2.98 | 70.97 | |
57 | Nature Cancer | journal | 9.817 Q1 | 44 | 169 | 285 | 6671 | 3373 | 183 | 11.84 | 39.47 | |
56 | Nuclear Medicine and Biology | journal | 0.512 Q4 | 96 | 65 | 197 | 2572 | 519 | 191 | 2.79 | 39.57 | |
55 | Cancer journal (Sudbury, Mass.) | journal | 0.880 Q2 | 98 | 70 | 217 | 3644 | 483 | 200 | 1.93 | 52.06 | |
54 | Cancer Investigation | journal | 0.598 Q3 | 90 | 89 | 215 | 3715 | 442 | 202 | 2.10 | 41.74 | |
53 | European Journal of Cancer Prevention | journal | 0.698 Q3 | 85 | 83 | 242 | 3220 | 541 | 212 | 2.20 | 38.80 | |
52 | Cancer Drug Resistance | journal | 0.815 Q3 | 17 | 71 | 222 | 6428 | 807 | 218 | 3.30 | 90.54 | |
51 | Current Problems in Cancer | journal | 0.612 Q3 | 46 | 58 | 242 | 2617 | 525 | 232 | 2.31 | 45.12 | |
50 | Cancer cytopathology | journal | 1.231 Q2 | 64 | 129 | 365 | 3521 | 1028 | 238 | 2.77 | 27.29 | |
49 | Oncology Research | journal | 0.658 Q3 | 63 | 23 | 250 | 1363 | 810 | 241 | 2.26 | 59.26 | |
48 | Nitric Oxide - Biology and Chemistry | journal | 0.928 Q2 | 104 | 71 | 245 | 5762 | 1105 | 242 | 4.08 | 81.15 | |
47 | Oncogenesis | journal | 1.610 Q1 | 60 | 67 | 252 | 3733 | 1501 | 251 | 5.86 | 55.72 | |
46 | Oncology | journal | 0.381 Q4 | 80 | 53 | 340 | 720 | 273 | 252 | 0.51 | 13.58 | |
45 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.650 Q3 | 66 | 94 | 261 | 3458 | 898 | 256 | 3.72 | 36.79 | |
44 | Current Opinion in Oncology | journal | 0.971 Q2 | 99 | 105 | 275 | 5423 | 890 | 256 | 3.11 | 51.65 | |
43 | Experimental Hematology | journal | 1.182 Q2 | 126 | 78 | 260 | 4141 | 685 | 258 | 2.66 | 53.09 | |
42 | Genes Chromosomes and Cancer | journal | 1.362 Q2 | 127 | 80 | 272 | 3828 | 1138 | 260 | 3.90 | 47.85 | |
41 | Melanoma Research | journal | 0.740 Q3 | 77 | 73 | 280 | 2106 | 712 | 263 | 2.05 | 28.85 | |
40 | JNCI Cancer Spectrum | journal | 2.377 Q1 | 25 | 75 | 309 | 2691 | 1211 | 278 | 3.68 | 35.88 | |
39 | Neoplasia | journal | 1.451 Q2 | 140 | 78 | 284 | 4322 | 1466 | 282 | 4.53 | 55.41 | |
38 | Epigenetics | journal | 1.408 Q2 | 105 | 160 | 285 | 10739 | 1446 | 285 | 4.11 | 67.12 | |
37 | Cytotherapy | journal | 1.186 Q2 | 99 | 137 | 318 | 6888 | 1442 | 303 | 3.91 | 50.28 | |
36 | JCO clinical cancer informatics | journal | 1.602 Q1 | 24 | 102 | 322 | 1574 | 1296 | 307 | 3.79 | 15.43 | |
35 | Trends in Cancer | journal | 3.581 Q1 | 75 | 107 | 322 | 7931 | 3662 | 310 | 11.28 | 74.12 | |
34 | Cancer Prevention Research | journal | 1.125 Q2 | 106 | 101 | 351 | 3293 | 1075 | 318 | 3.02 | 32.60 | |
33 | Stem Cell Reviews and Reports | journal | 1.067 Q2 | 82 | 217 | 359 | 17738 | 1764 | 324 | 4.79 | 81.74 | |
32 | Medical Oncology | journal | 0.777 Q3 | 87 | 256 | 355 | 13998 | 1096 | 333 | 3.12 | 54.68 | |
31 | Cancer Biology and Therapy | journal | 0.996 Q2 | 126 | 64 | 358 | 2710 | 1607 | 356 | 3.33 | 42.34 | |
30 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.916 Q2 | 85 | 81 | 402 | 2632 | 953 | 368 | 2.51 | 32.49 | |
29 | Molecular Imaging and Biology | journal | 0.748 Q3 | 75 | 113 | 401 | 4764 | 1233 | 381 | 3.05 | 42.16 | |
28 | Molecular Carcinogenesis | journal | 1.022 Q2 | 104 | 92 | 392 | 5634 | 1702 | 391 | 4.62 | 61.24 | |
27 | Cancer Cell | journal | 12.578 Q1 | 378 | 192 | 548 | 7019 | 12507 | 426 | 21.28 | 36.56 | |
26 | Anti-Cancer Drugs | journal | 0.471 Q4 | 98 | 239 | 429 | 3431 | 968 | 428 | 2.23 | 14.36 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2022. Data Source: Scopus®